Latest Ai Platforms News

Spectur Limited reported a 4.5% increase in quarterly revenue to $2.02 million and secured $2.15 million through a share placement to fund its AI-driven Sense-Think-Act platform development.

Decidr AI Industries has solidified its position in the agentic AI market by completing strategic acquisitions and launching its DecidrOS platform, achieving a 60% revenue increase in the December quarter.

dorsaVi reports strong US commercial growth with over 100 new physical therapy sites and a 50% rise in cash receipts, alongside a strategic leadership change and breakthrough neuromorphic technology acquisition.

Energy Action Limited reported positive operating cash flow for Q2 FY26 and secured a deferral on key loan repayments while investing in its AI-powered platform and appointing new board members.

ikeGPS Group has reported a robust 35% increase in its platform subscription revenue exit run rate for the nine months to December 2025, reaffirming its FY26 growth guidance amid strong market demand and new AI-driven product launches.

Northern Minerals has identified a promising new heavy rare earths target, the Vulcan prospect, through extensive drilling and soil sampling at its Browns Range project in Western Australia. This discovery, alongside advances in geological modelling and AI-driven exploration, signals a strategic step forward in the company’s rare earths ambitions.

Algorae Pharmaceuticals has advanced its AI drug discovery capabilities with the launch of AlgoraeOS v2 and secured key commercial partnerships, including a $3 million debt facility to support expansion in Australia and New Zealand.

Nanoveu Limited has marked significant progress in its 16nm ECS-DoT edge-AI system-on-chip development, secured a strategic $7.5 million capital raise, and earned top honours at CES 2026, positioning itself for commercial breakthroughs in 2026.

Hiremii Limited has reported its highest-ever quarterly revenue and gross profit, driven by growth in its recruitment business and enhanced AI technology. The company also completed a significant capital raise to accelerate its expansion plans.

Algorae Pharmaceuticals has locked in a $3 million revolving debt facility with ScotPac, providing flexible, non-dilutive funding to accelerate its commercial operations across Australia and New Zealand.

Unith Ltd has strengthened its financial footing by securing a $1 million unsecured facility and receiving initial R&D tax refunds from Spain, validating its advanced AI platform and supporting its growth ambitions.

Enlitic has locked in commitments for an A$8 million convertible note capital raise, with initial funds arriving immediately and the remainder pending shareholder approval. This funding aims to extend the company’s runway as it advances its AI-driven healthcare solutions.